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ABSTRACT 
Introduction. Cochlear implantation (CI) was a significant surgical innovation in the 20
th
 
century and represented the first artificial sensory organ that was applied in clinical 
medicine. Currently, CI is still one of the most effective medical procedures. Nonetheless, 
cochlear implantation in adults and children represents a controversial issue from an 
economic, clinical and ethical point of view, especially in specific clinical conditions that 
could compromise the CI outcome and drastically reduce the chance of an acceptable 
development of perceptual and linguistic capabilities. These conditions should certainly 
include the presence of inner ear malformations or brain abnormalities.  
Objectives. The aims of this work were to study the diagnostic value of high resolution 
computed tomography (HRCT) and magnetic resonance imaging (MRI) in children with 
sensorineural hearing loss who were candidates for cochlear implants and to analyse the 
anatomic abnormalities of the ear and brain in patients who underwent cochlear 
implantation. We analysed the effects of ear malformations and brain anomalies on the CI 
outcomes. Finally, we described the genetic mutations that we found in the study group. A 
control study group of implanted patients without ear and brain anomalies was obtained 
(virtually) from clinical and literature data for statistical purposes.  
Materials and methods. The present study is a retrospective observational review of 
cochlear implant outcomes among hearing-impaired children who presented ear and/or brain 
anomalies at neuroimaging investigations with MRI and HRCT. Furthermore, genetic results 
from molecular genetic investigations (GJB2/GJB6 and, additionally, in selected cases, 
SLC26A4 or mitochondrial-DNA mutations) on this study group were herein described. 
Longitudinal and cross-sectional analysis was conducted using statistical tests. 
Results. Between 1 January 1996 and 1 April 2012 at the ENT-Audiology Department of the 
University Hospital of Ferrara, 620 cochlear implantations were performed. There were 426 
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implanted children at the time of the present study (who were <18 years). Among these, 143 
patients (64 females and 79 males) presented ear and/or brain 
anomalies/lesions/malformations at neuroimaging investigations with MRI and HRCT. The 
age of the main study group (143 implanted children) ranged from 9 months and 16 years 
(average = 4.4; median = 3.0). The most common inner ear malformation is represented by 
an enlarged vestibular aqueduct; brain lesions are usually represented by white matter 
disorders. The 35delG in the GJB2 gene remain the most common mutation.  
Discussion and Conclusions. Good outcomes with cochlear implants are possible in 
patients who present with inner ear or brain abnormalities, even if central nervous system 
anomalies represent a negative prognostic factor that is made worse by the concomitant 
presence of cochlear malformations. Common cavity and stenosis of the internal auditory 
canal (less than 2 mm) are negative prognostic factors even if brain lesions are absent. 
Because the cochlear implantation is an invasive and expensive surgical procedure, the 
identification of predictive factors, even in hearing-impaired patients with cochlear and brain 
anomalies, is one of the most important goals, because it can help to guide rehabilitation 
programs that are tailored to meet the expectations of clinicians, teachers and parents. Our 
findings suggest that cochlear implantation (CI) is a safe and effective procedure even for 
patients with brain and inner ear abnormalities. Nonetheless, specific conditions, such as a 
common cavity, or in general, the absence of modiolus and the stenosis of the internal 
auditory canal, can increase the risk of post-operative complications and prevent the 
achievement of acceptable perceptual categories. For the aforementioned conditions, it is 
strictly recommended that cochlear implant indications, neuroimaging and surgery are 
performed in experienced hospitals. 
Keywords: inner ear malformations, brain abnormalities, cochlear implantation, 
neuroimaging, GJB2 mutations.  
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1. INTRODUCTION 
Cochlear implant (CI) was a significant surgical innovation in the 20
th
 century and 
represented the first artificial sensory organ applied in clinical medicine. Currently, CI is still 
one of the most effective medical procedures. It can evoke acoustic sensations by electrically 
stimulating the inner ear [1]. Nonetheless, cochlear implantation in adults and children 
represent a controversial issue from an economic, clinical and ethical point of view. The U.S. 
Food and Drug Administration (FDA) approved the use of cochlear implants as an auditory 
rehabilitation procedure in adults in 1984. Six years later, in 1990, the FDA approved 
cochlear implants also for children who were affected by severe-to-profound bilateral 
sensorineural hearing loss (with a tonal hearing threshold that is major, or equal to 90 dB 
nHL decibel normal hearing level, in the better ear), who were at least 1 year of age and who 
also did not have the benefit of adequate auditory training (typically from 4 to 6 months) 
with hearing-aid amplification (http://www.fda.gov/cdrh/cochlear/). A similar position was 
taken in 2007 in a statement of the Joint Committee on Infant Hearing, which noted that 
“Cochlear implantation should be given careful consideration for any child who appears to 
receive a limited benefit from a trial with appropriately fitted hearing aids. Infants with 
profound bilateral hearing loss are candidates for cochlear implantation at 12 months of 
age, and children with bilateral severe hearing loss are eligible at 24 months of age. The 
presence of developmental conditions (e.g., developmental delay, autism) in addition to 
hearing loss should not, as a rule, preclude the consideration of cochlear implantation for 
an infant or a child who is deaf” [2]. According to the U.S. Food and Drug Administration 
(FDA), as of December 2010, approximately 219,000 people worldwide have received 
cochlear implants [3]. Currently, there are three major FDA and EC (European Community) 
approved cochlear implant providers that are commonly used: Cochlear Ltd (Australia), 
Advanced Bionics (USA) and Med-El (Austria). The Neurelec’s devices (MXM – Neurelec 
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Corp, Vallauris, France) have not yet been approved by the FDA, but they have a CE 
registration and are currently used in Europe. All of the product devices comprise similar 
component parts: 1) an external unit, called a transmitter or processor, which constitutes a 
microphone, speech processor and batteries to drive the system; 2) an implanted device, 
called a receiver or stimulator, which can electrically stimulate the inner ear through an 
electrode array inserted into the cochlea. “The implant converts acoustic sound to electrical 
pulses that stimulate the auditory nerve. Acoustic input enters the microphone, which is 
worn on the ear, and is sent to the speech processor for analysis of intensity in a number of 
set frequency bands. The resulting information is sent from the externally worn transmitting 
coil to the subcutaneous receiver–stimulator through FM waves. These components are held 
together by a pair of magnets so that they are separated only by the thickness of the skin 
flap. Each frequency band is assigned to a particular electrode along the implanted array 
(mimicking the normal basal-to-apical organization of high to low frequencies in the 
cochlea). If instructed, this array will provide a biphasic electrical pulse to stimulate the 
auditory nerve. The magnitude of the pulse provided by any one electrode will depend on the 
acoustic intensity within the assigned frequency band and the dynamic range of current 
(minimum to maximum) programmed for that electrode” [4] (Fig. 1). The design of the 
electrode array must incorporate biocompatibility, mechanical stability and practical 
fabrication and must minimise insertion trauma. From a surgical point of view, efforts to 
reduce the insertion trauma must be accomplished at the materials and design levels as well 
as through the surgical technique. The CI has been devised to allow full access to verbal 
communication, through the perception of phonetic hallmarks. The success of this method is 
then given in general by the achievement of verbal communication performance by 
improving the skills of verbal perception, to become comparable to people with normal 
hearing. In the paediatric population, in children with profound hearing loss, which is 
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unsuitable for obtaining significant results with traditional hearing aids, CI (if performed 
early) allows the optimal development of auditory and linguistic abilities, which drives 
toward adequate communication and intellectual development.  
 
Fig. 1 - The internal (receiver) and external (transmitter) components of a cochlear implant. “The cross section of the 
cochlea shows the electrode array surgically placed in the scala tympani. The implant converts acoustic sound to electrical 
pulses that stimulate the auditory nerve. Acoustic input enters the microphone, which is worn on the ear, and is sent to the 
speech processor for analysis of intensity in a number of set frequency bands. The resulting information is sent from the 
externally worn transmitting coil to the subcutaneous receiver–stimulator through FM waves. These components are held 
together by a pair of magnets so that they are separated only by the thickness of the skin flap. Each frequency band is 
assigned to a particular electrode along the implanted array (mimicking the normal basal-to-apical organisation of high to 
low frequencies in the cochlea). If instructed, this array will provide a biphasic electrical pulse to stimulate the auditory 
nerve. The magnitude of the pulse provided by any one electrode will depend on the acoustic intensity within the assigned 
frequency band and the dynamic range of current (minimum to maximum) programmed for that electrode” [4]. 
On the other hand, the overall results of the cochlear implantation should not ignore the 
specific or unique conditions of the patients. It is known that auditory deprivation genres, 
first, have disadvantages in communication and reduction of daily activities that are closely 
Papsin BC, Gordon KA. Cochlear implants for children with severe-to-profound 
hearing loss. N Engl J Med. 2007;357(23):2380-7. 
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related to hearing impairment, and second, over time, involves other areas of personal life, 
leading in some cases to permanent deficits. For example, children with congenital profound 
hearing loss accumulate disadvantages over time in language skills and certain learning 
areas, which can lead to permanent limitations of personal skills at a later age. Because of 
the auditory habilitation/rehabilitation training with a cochlear implant, most of these 
patients can reach a complete disability "compensation". The effectiveness of CIs in adults 
and children is demonstrated by many contributions in the medical literature. Specifically, 
several studies have reported the results of the development of auditory perceptual and 
expressive verbal abilities in children with pre-, peri- and post-lingual deafness. Clinical 
experiences across the world have also shown that, among children with pre-verbal onset 
hearing loss, there is a critical period for the development of language skills, presumably due 
to the underlying neuronal plasticity, and learning would be strictly dependent on the 
presence of an adequate auditory input, which explains the need for early intervention to 
prevent the occurrence of a delay in language development and perceptive or expressive 
skills. A multi-centre study that was conducted on a large number of cases [5] showed that 
the majority of patients who were implanted reached the performance of verbal recognition 
more or less quickly depending on the age at the time of the implant surgery. 
The performance of the patients who received CIs varies significantly as a consequence of 
a substantial number of audiological and extra-audiological factors (age of hearing loss 
onset, duration of auditory deprivation, auditory function residuals, presence of associated 
disability and comorbidity, language skills at the time of the CI, duration of CI use, the 
presence of certain malformations of the inner ear, socio-economic status and familial 
environment) [6-13]. Even if a unique prediction of the results after CI is not yet available, 
mostly because of the extreme heterogeneity in the aetiology among profound hearing-
impaired patients, there are many prognostic factors that can contribute to the audiological 
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assessment. Among these, we emphasise the importance of inner malformations and brain 
anomalies, which are a part of the present study. 
Because cochlear implantation is an invasive and expensive surgical procedure, the 
identification of predictive factors is one of the most important goals; knowledge of the 
predictive factors can help to guide rehabilitation programs that are tailored to meet the 
expectations of clinicians, teachers and parents. The perceptual performance improves rather 
quickly if the selection criteria are correct. In agreement with research in the literature, the 
majority of patients who received a CI at our clinic have shown a rapid advancement in their 
perceptual abilities, reaching the 6
th
 perceptive category according to the Geers and Moog 
classification one year after surgery [14]. The perception of verbal sounds is an important 
starting point to activate the processes of linguistic acquisition. The development of 
language depends on auditory skills and maturation of cortical functions (memory, attention, 
intellectual abilities). The linguistic processes typically follow the perceptive processes with 
a variable latency, which appears to be related to the age of the patients at the time of 
surgery [15,16]. Specifically, children implanted in a very early age (8-12 months) 
experience linguistic evolution with a speed that is higher than that of normal hearing 
children of the same age, probably because of using lines of development in various 
linguistic domains that are different from the usual capabilities of normal hearing children. 
In other words, congenitally deaf patients develop many abilities to reach an adequate 
communication condition (lip-reading, visual reinforcement) that, when auditory function 
has recovered, work in synergy with auditory inputs, enhancing perceptual and visual skills; 
an analogous process is similar in visually impaired patients who develop, more than normal, 
auditory and olfactory skills. On the other hand, it cannot be excluded that the normal 
auditory input is more detailed and complex and, thus, that it takes more time to develop and 
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integrate superior central functions. In contrast, cochlear implant stimuli are simpler; thus, 
they do not need complex integration in the corpus callosum or cortical areas. 
With the advances in molecular genetics over the past 20 years, our understanding of the 
pathogenesis of sensorineural hearing loss has greatly increased. To date, more than 400 
syndromes have been described in which hearing loss is a regular or occasional feature [17] 
and, after more than two decades of molecular biological analysis, approximately 95 non-
syndromic recessive and 64 non-syndromic dominant loci have been identified [18], even if 
not all of them have led to the identification of specific genes. The most common mutations 
that are responsible for hearing loss involve the GJB2 gene; SLC26A4 mutations are the 
second cause of genetic hearing loss and the first among syndromic deafness. The SLC26A4 
(PDS) gene mutations result in abnormalities of the endolymphatic system, which lead to the 
dilation of the vestibular aqueduct as seen in Pendred syndrome. Nonetheless, other genes 
can be involved: normal expression of the PAX2 and PAX3 genes is necessary for the normal 
development of the cochlea. The FGF3 gene appears to be necessary for differentiation 
within the otic vesicle. The EYA1 gene has an important role in encoding transcription 
factors and mutations of EYA1 are responsible for EYA1-related disorders that include BOR 
(branchio-oto-renal) syndrome, BO (branchio-otic) syndrome and OFC (oto-facio-cervical) 
syndrome [19]. Several studies have shown that patients who have mutations of GJB2 (or 
Cx26) (OMIM * 121011) usually have excellent perception of speech and an optimal 
language development after the cochlear implant [20,21]. Additionally, it has been reported 
that GJB2 mutations are not usually accompanied by macroscopic inner ear malformations. 
Nevertheless, there is no evidence that genetic mutations or the interaction of a genetic 
diagnosis with other prognostic factors (such as abnormalities of the ear and brain) can 
predict CI outcomes. 
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Therefore, pre-operative neuroimaging is mandatory in cochlear implant candidates for 
diagnostic and surgical purposes. This step usually includes an MRI as well a high-
resolution computed tomography (HRCT) of the temporal bone. MRI should be performed 
with contrast (gadolinium), unless otherwise noted or unless the test is in children who are 
not believed to have lesions that require contrast to be diagnosed. HRCT of the temporal 
bone does not require iodine contrast. Note that Magnetic Resonance Imaging (MRI) is 
relatively contraindicated after cochlear implantation or it is arguably possible. Various 
experimental studies have shown that MRI scans can safely be performed with the CI in 
place [22,23]. This arrangement does not imply that it is generally safe to perform MRI in CI 
patients, because the type of implant, fixation method and MRI units and sequences could 
vary. Even if it can be performed safely, the distortion that is caused by the implanted 
magnet will cause sub-optimal interpretations [22]. For the aforementioned reasons, cochlear 
implantation can be contraindicated in patients who need periodic follow-up with MRI.  
At our clinic, pre-operative radiological imaging of cochlear implant candidates includes 
both HRCT and MRI of the temporal bone during the same session, during anaesthesia, if 
required, which usually occurs in children. In addition to the MRI of the inner ear, we also 
perform brain and brainstem MRI scans. These scans enable us to exclude any incidental 
brain abnormalities that can contraindicate CI surgery. MRI is the best diagnostic tool for 
detecting malformations such as cochlear nerve hypoplasia or aplasia, and it is the best 
screening tool for early cochlear ossification following bacterial meningitis [24-26]. HRCT 
provides better images and definition of the facial nerve canal, middle ear and otic capsule 
[27]. Central nervous system findings have been reported in 20–40% of the patients [25-29]. 
Some of these findings could result in neurodevelopmental delay and could negatively 
impact the outcome of cochlear implantation [30]. Nonetheless, increased experience in 
cochlear implantation has led to more children with abnormal cochleovestibular anatomy 
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being considered as candidates [12]. According to the literature, approximately 20% of the 
children who have sensorineural hearing loss have associated radiological anomalies of the 
temporal bone [31-33]. These temporal bone anomalies are accompanied by a wide range of 
hearing acuity, varying degrees of progression of hearing loss, and the presence or absence 
of related non-otological anomalies [33].  
The first cochlear implants in children with inner ear malformations were performed in 
the late 1980’s [33]. Since this time, cochlear implants have been fully described and 
surgical techniques have been tested; precautions have been identified that are necessary to 
prevent or remedy possible complications. Additionally, different electrode arrays have been 
developed that allow a choice of the most suitable array for the different types of 
malformations [13,34-39]. In general, “cochlear implantation is a relatively safe procedure 
with a low complication rate that ranges from 6% to 20%. Major complications are those 
that are life-threatening or require surgery, whereas minor complications are those that can 
be medically treated. The inner ear malformations can increase the risk of meningitis, 
cerebro-spinal fluid leakage and facial nerve palsy” [40,41]. We should note that “the rate 
of postoperative complications was higher in patients with anomalous inner ears than in 
patients with normal inner ears, most were minor and could be managed conservatively. 
These findings suggest that cochlear implantation (CI) is safe even for patients with 
anomalous inner ears in experienced hospitals” [41]. Nevertheless, the functional results 
reached by these children (perceptual and linguistic performance) are still poorly described 
and have not been predictable. Case studies have limited conclusions because of the high 
inter-individual variability. For these reasons, it is not yet possible to draw clear guidance 
from the literature on which to base the selection of candidates [12,13,41]. The 
malformations in fact allow the correct insertion of a number of electrodes that are usually 
sufficient, and the patterns of neural responses are adequate to accomplish the recognition of 
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an open set words. However, specific conditions that prevent a correct coupling between the 
electrode array and the cochlear nerve, even if the latter is present, such as a common cavity, 
are usually characterised by a poor outcome, unless very specific surgical strategies are 
enacted. 
 
1.1 Classification of inner ear abnormalities 
 
Approximately 80% of the children who have a congenital hearing loss have no 
macroscopic abnormalities of the ear, and their hearing loss is assumed to be the result of 
dysfunctions at a cellular level in the membranous inner ear. The remaining 20% can present 
inner ear dysplasia, which can be demonstrated on high-quality neuroimaging (HRCT 
without contrast and MRI, with contrast in adults or in specific cases). The inner ear 
abnormalities, whether dysplastic or nondysplastic, can be isolated or can be part of a multi-
organ syndrome [19]. In considering the problems specific to implanting children with ear 
malformations, it is valuable to consider the normal development of the inner ear. “During 
the third week after conception, the otic placode appears on the surface ectoderm. This 
becomes invaginated to form the otic pit and, in turn, the otic vesicle or otocyst by the end of 
the fourth week. The vesicle divides into a ventral component, which gives rise to the saccule 
and the cochlear duct, and a dorsal component, which forms the utricle, semicircular canals, 
and endolymphatic duct. In the sixth week, the saccule forms a tubular outpocketing at its 
lower pole, the cochlear duct. This penetrates the surrounding mesenchyme and by the end 
of the eighth week has completed 21.2 turns. In the 10th week, vacuolisation in the 
surrounding mesenchyme around the cochlear duct forms the scala tympani and vestibuli, 
and following that membranous structures such as the organ of Corti begin to develop in the 
cochlea. The semicircular canals appear as outpocketings of the utricle about the sixth week. 
The central portions of these outpocketings eventually become opposed to each other and 
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disappear giving rise to the three semicircular canals. The endolymphatic sac and duct is 
initially a wide structure, but the proximal portion, the duct narrows about the seventh week. 
If there is no developmental arrest before the eighth week, a normal cochlea is formed [24]. 
The statoacoustic ganglion forms from neural crest cells and cells derived from the otic 
vesicle. It subsequently splits into cochlear and vestibular components, the spiral ganglion 
and Scarpa’s ganglion. There is increasing interest in the genetic and molecular factors that 
drive this complicated process [19].  
In considering the specific problems for the implant of children with deafness associated 
with inner ear malformations, it is worthwhile to consider the normal anatomy of the inner 
ear (Fig. 2). The cochlea has a discrete anatomical variability in its shape and dimensions, as 
reported by several authors [42-48]. In humans, “cochleae are mirror-shaped, fluidfilled, 
coiled, fairly symmetrical bony tubes (3.2–4.2 cm long) situated in the petrous pyramids of 
the temporal bones. Cochlea is composed of ~2 and three-fourth turns. The outer cochlear 
wall had a mean length of 42.0 mm while the first turn was 22.6 mm (range, 20.3–24.3 mm) 
representing 53% of the total length. The total height of the cochlea can vary from 4.4 to 5.9 
mm (mean 5.1 mm). The large variations in cochlear lengths, angles between turns, and 
position in the skull base can influence the straightforwardness for the insertion of a CI 
electrode particularly passing the first turn. Most frequently damaged are the spiral 
ligament at the junction of the first and second half of the first turn, basilar membrane (BM), 
and osseous spiral lamina” [48]. “The average LSCC (lateral semicircular canal) bony 
island width is 3.7 mm (normal range, 2.6-4.8 mm). Cochlear hypoplasia (< 4.4 mm) had a 
positive predictive value of 100% for SNHL, whereas cochlear hyperplasia and bony island 
dysplasia were less predictive” [44].  
Developmental malformations that affect the otic capsule result in anomalies of both the 
membranous and bony labyrinth. The specific timing of the insult during otic capsule 
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development determines the resulting type of malformation along a spectrum of congenital 
inner ear malformations that can occur when the normal process of development is impacted, 
even if it is not necessarily understood why this result occurs.  
 
 
Fig. 2 - MRI and CT scans showing normal inner ear anatomy. The total length of the cochlear partition ranges from 
38.6 to 45.6 mm (average 42.0 mm.). The length of the basal turn (53% of the total length) ranges from 20.3 to 24.3 mm. 
The width of the internal auditory canal is between 4.85 and 5.02 mm. The height ranges from 4.39 to 4.62 mm and the 
length from 11.22 to 11.44 mm [48]. 
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The best review of these developmental anomalies is given by Sennaroglu and Saatci [24-
25], which is an update on the valuable original work by Jackler et al. [31], and the present 
study is essentially based on their classification (Tab. I) [45]. Table II shows the recurrence 
rate of different temporal bone malformations [46]. No cases of variations in the dimension 
of the facial recess have been reported. 
 
COCHLEAR 
MALFORMATIONS 
DESCRIPTION % 
Michel deformity Complete aplasia of all of the inner ear structures. This condition can 
be associated with aplasia of the internal auditory canal. 
6 
Cochlear aplasia Absent cochlea in the presence of a normal, dilated, or hypoplastic 
vestibule and semicircular canal system. The internal meatus might be 
normal. 
5 
Common cavity Round or ovoid structure that represents the cochlea and vestibule. 
The cochlear nerve might be absent. 
8 
Cochleovestibular 
hypoplasia 
Cochlear and vestibular structures are clearly seen to be separate from 
each other. The cochlea is smaller than normal but might have a 
normal internal architecture (cochlea height < 4.4 mm and less than 
2.5 turns). The cochlear aperture could be aplastic, and the cochlear 
nerve might be absent. 
12 
Incomplete partition 
type I (IP1): cystic 
cochleovestibular 
malformation 
Cystic cochlea (the absence of partitions and cochlea has cystic 
aspects; furthermore, the modiolus and cribriform areas are absent) 
and dilated vestibule. Most cases have an abnormal internal auditory 
canal (IAC) with an absent lateral wall of the IAC. 
20 
Incomplete partition 
type II (IP2): Mondini 
malformation 
Cystic cochlear apex (the cochlea has a normal basal turn but the 
medial and apical turns are fused together, leading to a one and and a 
half turn cochlea) 
Minimally dilated vestibule 
Large vestibular aqueduct 
19 
Incomplete partition 
type III (IP3); X-linked 
deformity/deafness. 
This condition is similar to IP1, except for the presence of the 
interscalar septa; the modiolus is absent. It could be misdiagnosed as a 
mixed type hearing loss. 
2 
Tab. I. – Classification of cochlea malformations [45]. 
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Enlarged vestibular aqueduct (EVA) is the most common radiologically detectable inner 
ear malformation that is associated with hearing loss. Approximately 80% of hearing 
impaired patients with at least one mutation in the SLC26A4 gene presented EVA at 
neuroimaging. Nevertheless, EVA can be associated with other conditions, such as 
Waardenburg syndrome or BOR (branchio-oto-renal) syndrome.  
 
MALFORMATIONS FREQUENCY 
Malformed ossicles 67% 
Abnormal oval window 57% 
Facial Nerve Anomalies 57% 
Enlarged Vestibular Aqueduct (EVA) 52% 
Enlarged Cochlear Aqueduct (ECA) 43% 
Abnormal round window 29% 
Middle ear aplasia 19% 
Tab. II – Recurrence rates of the temporal bone malformations [46]. 
 
Malformations of the inner ear that represent an absolute contraindication to the IC are 
the bilateral aplasia of the cochlea or cochlear nerve. Aplasia of the cochlear nerve is 
frequently in the presence of a common cavity, CHARGE association and when the internal 
auditory canal has a diameter of less than 2 mm [25,47]. Other causes are rare syndromes 
such as LAMM [49] and Möbius. Hypoplasia of the cochlear nerve is not an absolute 
contraindication to the CI, but it could lead to reduced performances [12,13]. 
Anomalies of the facial nerve, malformations that increase the risk of gusher (such as 
enlarged vestibular aqueduct, absence or hypoplasia of the modiolus, dilation of the vestibule 
or semicircular canals and stenosis of the round window), common cavities, and abnormal 
vessel paths can complicate the surgical approach. 
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Finally, some malformations of the inner ear, such as common cavity, absence or hypoplasia 
of the modiolus, can complicate the fitting and can require repeated control mapping due to 
the instability of the electrode array inside the malformed cavity.  
In summary, the various types of inner ear malformations could have quite different 
prognoses for auditory performance after a CI depending on the degree of the dysplasia. It 
should be emphasised that no single centre has, as yet, assembled a very large series of 
cochlear implants in dysplastic ears or brain abnormalities; thus, a clear picture of the 
expected outcomes in different groups is not possible at this stage. 
 
1.2 Brain anomalies and hearing loss 
 
A comprehensive review of brain anomalies is not an objective of the present study. Even 
if updating revisions of central nervous system (CNS) abnormalities are available in the 
literature, they were not discussed in this research. In theory, every CNS lesion can be 
responsible for hearing loss. In clinical practice, CNS lesions are usually represented by: 
neoplasms/neoformations, malformations, vascular/ischemic and gliotic lesions, white-
matter disorders, demyelinating disorders, and viral/bacterial infections (meningitis and 
cytomegalovirus infections). 
 
1.3 Objectives 
 
The aims of this work were to study the diagnostic value of HRCT and MRI in children 
who have sensorineural hearing loss and who were candidates for cochlear implants; we also 
aim to analyse anatomic abnormalities of the ear and brain in patients who underwent CI. 
We analysed the effects of ear malformations and brain anomalies on the CI outcomes. 
Finally, we described the genetic mutations that we found in the study group. A control 
study group of implanted patients without ear and brain anomalies was obtained (virtually) 
from clinical data and literature data for statistical purposes.  
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MATERIALS AND METHODS 
This study is a retrospective observational review of cochlear implant outcomes among 
hearing-impaired children who presented ear and/or brain anomalies at neuroimaging 
investigations with MRI and HRCT. Furthermore, genetic results from molecular genetic 
investigations (GJB2/GJB6 and, additionally, in selected cases, SLC26A4 or mitochondrial-
DNA mutations) on this study group were herein described. Longitudinal and cross-sectional 
analyses were conducted using statistical tests. To create more homogenic groups and more 
study-specific findings (e.g., EVA) and to obtain more significant analysis, the main study 
group was divided into different subgroups, which were named with alphabetic letters, as 
follows (Tab. III): 
 
STUDY GROUPS INCLUSION CRITERIA 
MAIN STUDY GROUP 
Cochlear implant recipients who had less than 18 years of age at the time of surgery and 
who presented neuroradiological findings at pre-operative neuroimaging investigations. 
SUBGROUP A Patients with inner ear malformations (with or without brain anomalies) 
SUBGROUP B Patients with internal auditory canal stenosis 
SUBGROUP C Patients with only inner ear malformations (without brain anomalies) 
SUBGROUP D Patients with only brain anomalies (without inner ear malformations) 
SUBGROUP E 
Patients with inner ear malformations AND brain lesions or abnormalities (with brain 
anomalies) 
SUBGROUP F Monolateral CI 
SUBGROUP G Bilateral CI 
SUBGROUP H < 3 years of age at the time of surgery 
SUBGROUP I > 3 years of age at the time of surgery 
SUBGROUP J Patients with genetic mutations 
SUBGROUP K Cytomegalovirus 
SUBGROUP L Meningitis (as a cause of hearing loss) 
SUBGROUP M Patients who presented EVA 
SUBGROUP N CHARGE association 
SUBGROUP O Demyelination 
SUBGROUP P Gliosis 
SUBGROUP Q Leukomalacia 
SUBGROUP R Only cochlear malformations 
 
Tab III – The study groups of the present research. 
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A control study group was created starting from literature data and randomised selected 
cases (from our casuistry) of implanted children without neuroradiological findings. A long-
term follow-up was performed, which reported that the Geers and Moore score was achieved 
at 3, 6, 12, 24, and 36 months. Each of the subgroups was compared with the control study 
group. Furthermore, the subgroups were compared with each other only if the same patients 
were not present in either. Specific findings were reported as singular cases. A non-
parametric test was used for statistical analysis: the Mann-Whitney U test. Furthermore, we 
used the ANOVA test (analysis of variance) for the comparison between patients with 
monolateral CI and patients with bilateral CI. 
 
2.1. Audiological assessment. 
 
Before implantation, all of the children had documented severe to profound or profound 
sensorineural HL (hearing loss) and failed an appropriate hearing-aid trial. Each patient has 
been investigated from an audiological point of view using objective tests, such as OAEs 
(otoacoustic emissions), ABR (auditory brainstem response), and ASSR (auditory steady 
state response), to estimate the pure-tone threshold and, in selected cases, to perform 
ECochG (electrocochleography). When possible, the audiological assessment was completed 
using behavioural and tonal audiometry with and without previously described hearing aids.  
Children of 6-36 months of age underwent conditioned orientation reflex (COR) and visual 
reinforcement audiometry (VRA) tests to investigate the tonal threshold at low frequencies 
and to assess the effectiveness of the hearing aids. From the age of three to four years, the 
pure-tone hearing thresholds can be obtained by motivational games that range from peep 
shows to finger-raising techniques, and at an age of six years, most children can perform 
formal audiometry the same as that used in adults. The testing is dependent only on the 
degree of cooperation of the child and the experience of the tester. Micro-otoscopy, 
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tympanometry and recording of stapedius reflex thresholds were part of the test procedure. 
The interpretation and diagnostic validity of stapedius-reflex-threshold testing in children are 
similar to the testing of adults, but the test might be difficult to perform in very young children. 
 
2.2. Imaging data 
 
High resolution HRCT (High Resolution Computed Tomography) and MRI (Magnetic 
Resonance Imaging) were conducted in all patients to obtain a radiological examination of 
the temporal bone and brain. If necessary, children underwent neuroradiological scans 
during general anaesthesia. HRCT scanning with contiguous 0.3 - 1 mm thick images 
through the petrous temporal bone in the axial and direct coronal planes was performed. Ear, 
brainstem and encephalon MRI scanning was acquired at 1.5 T and included high resolution 
axial and coronal T2-weighted imaging axial and coronal T1-weighted imaging, using CISS 
(Constructive Interference in Steady State) and FIESTA (Fast Imaging Employing Steady-
state Acquisition). If contrast was required, then post-contrast T1-weighted images were 
acquired in all three planes. CISS and FIESTA are a gradient-echo MRI sequence that are 
used to investigate a wide range of pathologies when routine MRI sequences do not provide 
the desired anatomic information. MRI brain scanning was also acquired at 1.5 T and 
included axial T2-weighted imaging, axial fast fluid-inversion recovery sequence (FLAIR) 
imaging, axial T1-weighted inversion recovery imaging and, if contrast was required, axial 
T1-weighted imaging.  
The neuroimaging findings of the temporal bone were categorised as:  
1) Cochlear malformations  
2) Vestibular and semicircular canal malformations  
3) IAC (internal auditory canal) anomalies  
4) EVA (enlarged vestibular aqueduct) 
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The vestibular aqueduct is defined as enlarged if its diameter is greater than 1.5 mm at the 
midpoint. Vestibular and labyrinthine abnormalities included partial SCC aplasia and total 
SCC aplasia. Cochlear malformations were subsequently divided as follows:  
1) Cochlear malformations  
a. Common cavity deformity.  
b. Cochlear hypoplasia.  
c. Incomplete partition type I (IP-I).  
d. Incomplete partition type II (IP-II) (Mondini deformity). 
e. Incomplete partition type III (IP-III) 
f. Basal turn dysplasia. 
Mondini malformation is a cochlear anomaly that is characterised by a fusion of the apical 
and middle turn (only one and a half turns is present out of the normal two and a half turns).  
The brain MRI scans of all of the patients were reviewed, and all of the abnormal findings 
were identified and classified as follows: 
1) Malformations 
a. Aplasia, dysplasia or hypoplasia 
b. Dilatations 
c. Arnold-Chiari malformations 
2) Neoformations 
a. Neoplasms (benign or malignant) 
b. Cystic lesions 
3) White matter disorders 
a. Leukomalacia 
b. Leukodystrophy 
c. Demyelination 
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4) Gliotic lesions (including cytomegalovirus infections and ischemic lesions) 
5) Other abnormalities 
 
2.3. Genetic and molecular analysis 
 
Informed consent was obtained from patients and parents according to current national 
rules and laws. Molecular genetic studies of the GJB2, GJB6, SLC26A4 genes and 
mitochondrial DNA (mit-DNA) were performed in 77 patients. Genomic DNA was extracted 
by standard protocols from peripheral blood leukocytes of patients. Direct DNA sequencing 
of the GJB2 gene (including analysis of the entire coding region) was performed. PCR 
amplification of the coding 21 exons, the flanking and promoter regions of the SLC26A4 
gene was performed using specific primers. Amplification reactions were performed in a 
final volume of 25 ml containing 100 ng of genomic DNA, 200 mmol/l dNTPs, 10 mmol/l 
each primer 1.5 mmol/l MgCl2, and 1 U of Taq polymerase. After 5 min of denaturation at 
94°C, 35 PCR cycles were carried out, each cycle comprising 45s of denaturation at 94 °C, 
45s of annealing at 60 °C and 80s of extension at 72°C. Direct sequencing of the PCR 
products on both strands was performed on an ABI PRISM 3130xl sequencer, using the ABI 
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems by Life Technologies). 
 
2.4. Speech perception (pre-operative assessment and post-operative outcomes): 
 
Behavioural measures of speech perception scores [50-54] are routinely completed in all 
children in our study at follow-up visits and a database of these outcomes is maintained. The 
database also includes patient demographics (age at implant, gender, duration of implant 
use), audiological characteristics (congenital vs. progressive loss) and relevant medical 
history (other medical conditions, such as craniofacial syndromes). 
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Perceptive abilities are usually classified into 4 types of increasing complexity 
performances [52]: 
1) Detection: ability to respond to the presence or absence of a signal; 
2) Discrimination: ability to distinguish differences or similarities between two stimuli;  
3) Identification: ability to choose an item from a known set;  
4) Recognition: ability to repeat or imitate spoken stimuli. 
The achieved performance enabled us to include each patient in a specific perceptual 
category. Geers and Moog propound perceptive classification with six categories, which are 
based on performances that have been analysed with sets of specific tests (Tab. IV) [14]: 
Category 0 no detection of verbal sounds 
Category 1 detection of verbal sounds 
Category 2 discrimination of verbal sounds 
Category 3 identification of verbal sounds 
Category 4 closed set vowel recognition  
Category 5 closed set consonant recognition  
Category 6 open set recognition  
Tab IV- Geers and Moog perceptive categories classification. 
 
Geers & Moog perception was used for the present study. A comparison of specific speech 
perception tests was conducted between hearing impaired children with normal anatomy 
(called “well babies”) and those who were affected by cochleovestibular and brain 
abnormalities. An excellent tool for monitoring progress in young children is the Clinical 
Red Flag Procedure [50], which is a matrix of auditory benchmarks that has been established 
for identifying children who are progressing at a slower-than-expected rate. These 
benchmarks are based on research and clinical findings that document the listening skills that 
are achieved by the average CI child during the first year of device use (fig. 3). Three 
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different groups of CI children reflect different pre-implant characteristics and show 
different patterns of skill achievement [50]. 
 
 
Fig. 3 - Clinical red flags for slow progress in children with cochlear implants. Red flag Matrix for monitoring listening 
progress in the first year of CI use. Robbins (2005). *Note that full-time implant use is an unconditional prerequisite to 
auditory development. If a child is not wearing the implant during all waking hours—at home, school, and other activities, 
then these benchmarks are not applicable. Children who fail to bond to their device and to wear it full-time within a few 
weeks of initial stimulation may exhibit insufficient progress and are at high risk of becoming non-users of their implants. 
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It appears evident that in the "well babies", the perceptual expected results after 3 months 
of use of the CI essentially comprise the detection of voice and first discrimination abilities 
until the recognition of words and phrases without the help of lip reading at 1 year of CI use. 
In summary, the expected perceptual results were the achievement of perceptual category 2 
at 3 months from the CI activation, perceptual category 4 at 6 months and perceptual 
category 6 at 12 months. The follow-up initially should be very tightly controlled and should 
be performed in the first year after surgery, at 3, 6, 9 and 12 months and then yearly. The 
evaluation of perceptual skills and communication has been made by the administration of 
different tests according to the stage of language development of the child (pre-verbal stage, 
transitional stage and functional stage). 
 
2.4.1. Listening Progress Profile (Lip) (developed by Archbold 1994) 
The LIP is a profile that is designed to monitor changes in early auditory perception of 
young children and is most commonly used with children who use cochlear implants. Two 
types of nonlinguistic sound perception abilities are monitored using this profile: 
environmental sound awareness and environmental sound discrimination. LIP also monitors 
speech perception abilities [51]. The LIP identifies three different skills: response, 
discrimination, and identification. The response skill is used to describe the detection of a 
sound. Discrimination is used to describe the ability for the child to choose correctly 
between two different sounds. Identification is used to describe the ability to correctly 
choose the target sound from an open set of sounds. The child is then scored on each of these 
skills in the following way: N (Never/not known), S (Sometimes), and A (Always). These 
responses can be elicited or observed. The profile is structured as a list of behaviours or 
skills such as “Response to Environmental Sounds”.  
There are six skills that pertain to nonlinguistic sounds and ten skills that relate to linguistic 
sounds: 
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1. Response to a drum 
2. Response to a musical instrument  
3. Discrimination between 2 different instruments 
4. Discrimination between a loud and quiet drum 
5. Discrimination between a single and repeated drum 
6. Identification of environmental sounds 
7. Speech detection (elicited) 
8. Speech detection (spontaneous) 
9. Linguistic sound detection 
10.  Short/Long discrimination of verbal material 
11. Single/Repeated discrimination of verbal material 
12. Soft/Loud discrimination (intensity discrimination) 
13. Discrimination of at least 2 linguistic sounds  
14. Discrimination of at least 5 linguistic sounds 
15. Discrimination between 2 words of different lengths  
16. Identification of own name 
Additionally, little information is offered on the types of sounds that the child can identify or 
comprehend. Using the LiP test, we can see that the median percentage is achieved by the 
single age groups at different testing times after implantation. Children who are older than 5 
years at the time of their implantation reached the maximum score on the LiP 1 year after 
implantation. Children between 3 and 5 years at the time of their implantation scored highest 
1.5 years after implantation. The children who received implants at the youngest ages (<3 
years) reached their highest possible value approximately 2 years after implantation. 
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Fig. 4. Evaluation of Auditory Responses to Speech - Normative Data Med-El, Innsbruck (1998) 
 
2.4.2. Early Speech Perception Test (ESP) (Moog & Geers, 1990) 
Italian version: PCAP (Test di misurazione delle Prime Categorie Percettive) (Arslan et 
al. 1997). This test measures the child’s ability to discriminate different words based on 
specific perceptual features. Therefore, it is possible to include each child in one of four 
perceptual categories [14]. The standard version was designed to obtain accurate information 
about the progression of speech discrimination skills in children who have profound hearing 
impairments as they develop. The standard verbal version was designed for children who are 
at least 6 years. The stimuli are composed of 36 words that are presented in an auditory-only 
condition as three subtests of 12. The format is closed-set. Each subtest is administered using 
both visual and auditory input to differentiate speech perception skills from language ability. 
The low verbal version was designed to estimate speech perception abilities in very young 
children (a minimum of 2 years) who have limited verbal abilities. Stimuli comprise words 
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that vary in pattern as well as spondees and monosyllabic words presented in sets of four. 
The format is a four-item closed-set format and can be presented via live voice or a 
recording. Test materials constitute objects (toys) instead of pictures. 
 
2.4.3. GASP (Glendonald Auditory Screening Procedure) (Erber, 1982)  
Italian version: TAP (Test delle Abilità Percettive) (Arslan et al. 1997). This test 
measures the ability to understand simple sentences, and it also uses only one type of 
sentence structure (questions). This arrangement is useful because children can become 
confused when faced with different sentence structures (questions, commands or statements) 
in the same test. Children are allowed to either repeat the question or to answer it. This test 
comprises 3 subtests [52]: 1) detection, 2) identification and 3) comprehension. 
1) DETECTION: 
a. purpose  
i. to determine the device settings and to check whether the CI is 
working; 
ii. to attract a child's attention and to orient him or her to the listening 
task;  
iii. to determine which sounds are available to the child;  
b. response  
i. repeatedly says a new word in a meaningful context.  
There is rarely any need to spend much time at this level, although it could be worthwhile to 
help the child to detect those sounds, such as fricative consonants, which are low in acoustic 
energy. 
2) IDENTIFICATION: 
a. purpose 
i. to apply labels to speech stimuli that can be discriminated; 
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ii. to learn speech patterns; 
b. response 
i. point to an item named by the speaker, repeat stimulus, write 
stimulus.  
When writing sentences, it is a good idea to construct sentences that have some relevance to 
the children. It is best to attempt to make sentences that are sufficiently different in length 
and/or pattern to enable all children in the group to achieve some success in identification.  
When presenting an identification task, include "no sound" (the absence of sound) as a 
response option. This option helps the child to become aware of the possibility that he or she 
might hear nothing, and thus, the child can learn to indicate that the IC is off, has a dead 
battery, or is faulty. A response of "no sound" could also indicate that the talker is too far 
away from the child. 
3) COMPREHENSION: 
a. purpose 
i. To understand the meaning of a spoken stimulus  
ii. To make complex associations between sounds and events/objects 
or between the sounds themselves  
b. response  
i. The child performs the required task or answers questions. 
 
2.4.4. Northwestern University – Children’s Perception of Speech (NU-CHIPS) - (Elliot 
and Katz, 1980)  
Italian version: T.I.P.I.1 (Test di Identificazione Parole Infantili 1) (Arslan et al.1997). 
NU-CHIPS is a closed-set picture-pointing word recognition test for children. This test is 
composed of 50 words that are familiar to three-year-old children in four randomisations 
called forms. The test includes one CD-Rom, which contains two picture books with 50 
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monochrome plates, with four pictures per plate. There are two recordings, with one male 
speaker and one female speaker. [53] 
 
2.4.5. Word Intelligibility by Picture Identification (WIPI) (Ross and Lerman, 1979) 
Italian version: T.I.P.I.2 (Test di Identificazione Parole Infantili 2) (Arslan et al. 1997). 
This test is a closed-set discrimination task in which the child must identify the stimulus 
word from a set of six pictures. The recommended age is a minimum of 4 years. The stimuli 
are composed of four lists of 25 single-syllable words. Chance performance amounts to a 
score of approximately 18%. This discrimination task is more difficult than the majority of 
other closed-set discrimination tasks in that the vocabulary level is higher and the response 
choices differ in fine segmental information [54]. 
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3. RESULTS 
 
Between 1
st 
January 1996 and 1
st
 April 2012 at the ENT-Audiology Department of the 
University Hospital of Ferrara, 620 cochlear implantations were performed. There were 426 
implanted children at the time of the present study (who were <18 years).  
Reviewing the neuroradiological findings of the 426 implanted children revealed no 
abnormalities in 283 cases and ear and / or brain anomalies in 143 cases (33.6% of 426). 
Among these 143 patients (64 females and 79 males), 123 children had unilateral cochlear 
implantation (68 in the right ear; 55 in the left ear), and 20 underwent bilateral cochlear 
implantations (3 simultaneously, 17 sequentially). The age of the main study group (143 
implanted children) ranged from 9 months and 16 years (mean = 4.4; median = 3.0). These 
patients showed an average period of cochlear implant use of 74 months. 
The CT and MRI scans of 143 children included in the present study were re-evaluated, and 
the following abnormalities were detected: in 69 cases (48.2% of 143), ear malformations 
were present, of which 55 had bilateral ear involvement; therefore the implanted ear was 
necessarily the malformed ear; in 11 children, the malformed ear was the right ear (of which 
only in one case the malformed side was the implanted side), and in 3 cases, the 
malformation was detected in the left side (also in this series only one child underwent 
cochlear implantation in the malformed ear); 74 cases (51.7% of 143) presented only brain 
anomalies. A total of 45 patients (31.5% of 143) presented either ear or brain abnormalities. 
Table V shows different aetiologies of hearing loss that we found in our series. Details of the 
identified cochleovestibular (inner ear) malformations are presented in Table VII and VIII. 
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Aetiology Number of Patients % 
Unknown 27 18.9 
Cytomegalovirus infection 26 18.2 
GJB2 mutations  24 16.8 
Acquired conditions (prematurity, perinatal suffering/icterus) 16 11.2 
Enlarged Vestibular Aqueduct (EVA) 14 (4 Pendred Syndromes) 9.8 
Cochleovestibular malformations 14 9.8 
Meningitis/encephalitis 12/1 9.1 
CHARGE association 3 2.1 
Hydrocephalus 2 1.4 
Waardenburg Syndrome (with dilated vestibule and bilateral cochlear 
dysplasia) 
1 
0.7 
Möbius Syndrome (with microtia and facial nerve aplasia) 1 0.7 
Williams Syndrome (with EVA and semicircular canal dysplasia) 1 0.7 
Other conditions (neurosurgery) 1 0.7 
Total 143 100 
TAB V - Suspected main aetiology of hearing loss among 143 children who underwent cochlear implantation and presented 
ear or brain anomalies.  
 
Demographic groups and audiological features are resumed in Table VI.  
 
 EXTERNAL 
EAR 
MALFORMATI
ONS (TOTAL 
N°= 3 CASES) 
MIDDLE EAR 
MALFORMATIO
NS (TOTAL N°= 
18 CASES) 
INNER EAR 
MALFORMATIO
NS (TOTAL N°= 
30 CASES) 
BRAIN 
ANOMALIES 
(TOTAL N°= 119 
CASES) 
WITHOUT 
BRAIN 
ANOMALIES 
(TOTAL N°= 
24 CASES) 
SEX (FEMALE:MALE) 1:2 9:9 11:19 55:64 9:15 
MEAN AGE (in years) AT 
THE TIME OF SURGERY 
3.0 3.0 4.4 4.0 7.0 
MEAN PERIOD (in months) 
OF USING COCHLEAR 
IMPLANT 
78 73 74 75 71 
IMPLANTED EAR (°) 2L, 1R 8L, 7R, 3B 11L, 15R, 4B 42L, 61R, 16B 13L, 7R, 4B 
% OF PROGRESSIVE 
HEARING LOSS 
- 22.2% 30.0% 45.3% 54.1% 
CYTOMEGALOVIRUS 
INFECTIONS 
- 3 2 26 - 
MENINGITIS - - 1 11 1 
GENETIC MUTATIONS - 2 5 21 3 
SYNDROMES 3 3 5 6 4 
UKNOWN AETIOLOGY - 3 - 26 1 
OTHER CONDITIONS (*) - 2 2 19 1 
Tab. VI – Demographic, clinical and audiological data and aetiologies of hearing loss; ° (R=RIGHT; L=LEFT; 
B=BILATERAL); * (infant cerebral palsy, prematurity, perinatal suffering, hydrocephalus, ischemia, neonatal icterus).  
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 COCHLEAR 
MALFORMATIONS 
(TOTAL N°=21 
CASES) 
VESTIBULAR AND 
SEMICIRCULAR CANAL 
MALFORMATIONS (§) 
(TOTAL N°=24 CASES) 
ABNORMAL 
INTERNAL AUDITORY 
CANAL (•) 
(TOTAL N°=15 CASES) 
EVA  
(N°=21 
CASES) 
SEX (FEMALE:MALE) 6:15 10:14 10:5 10:11 
MEAN AGE (in years) AT 
THE TIME OF SURGERY 
4 4 5 7 
MEAN PERIOD (in months) 
OF USING COCHLEAR 
IMPLANT 
75 77 84 54 
IMPLANTED EAR (°) 8L, 11R, 2B 6L, 13R, 5B 7L, 8R 12L, 7R, 2B 
MALFORMED SIDE (°) 1L, 2R, 18B 1L, 2R, 21B 1R, 14B 1L, 3R, 17B 
% OF PROGRESSIVE 
HEARING LOSS 
28.6% 41.6% 26.6% 71.4% 
Tab. VII – Anatomic distribution of inner ear malformations; ° (R=RIGHT; L=LEFT; B=BILATERAL); §(6 
HYPOPLASIAS; 7 DILATATIONS; 3 APLASIAS); •(7 STENOSIS; 8 DILATATIONS). 
 
 
 COMMON 
CAVITY 
COCHLEAR 
HYPOPLASIA 
(TOTAL N°= 6 
CASES) 
INCOMPLETE 
PARTITION 
TYPE 1 
(TOTAL N°= 2 
CASES) 
INCOMPLETE 
PARTITION 
TYPE 2 
(TOTAL N°= 7 
CASES) 
INCOMPLETE 
PARTITION 
TYPE 3 
(TOTAL N°=2 
CASES)  
COCHLEAR 
BASAL TURN 
DYSPLASIA 
(TOTAL N°= 4 
CASES) 
SEX (FEMALE:MALE) - 2:4 0:2 3:4 1:1 0:4 
MEAN AGE (in years) AT 
THE TIME OF 
SURGERY 
- 5 3 5 7 2 
MEAN PERIOD (in 
months) OF USING 
COCHLEAR IMPLANT 
- 59 82 85 77 73 
IMPLANTED EAR (°) - 2L, 4R 1L, 1R 2L, 4R, 1B 1L, 1R 2L, 1R, 2B 
MALFORMED SIDE (°) - 1L, 1R, 4B 2B 1R, 6B 2B 4B 
% OF PROGRESSIVE 
HEARING LOSS 
- 40% - 28.6% 50% 25% 
Tab. VIII – Types of cochlear malformations; ° (R=RIGHT; L=LEFT; B=BILATERAL). 
 
Finally, Table IX reports in detail the brain anomalies that were found, with the total number 
of cases for each type. 
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Type of lesion/malformation 
Total number of cases  
among 143 implanted children 
Gliosis 32 
Dismyelination/demyelination 25 
Leukomalacia 24 
Pineal cyst 9 
Arnold-Chiari malformation (type 1) 7 
Cerebellar hypoplasia  6 
Cortical dysplasia 5 
Calcifications 3 
Arachnoid cyst 3 
(External) Hydrocephalus  3 
Dilated lateral ventricles 2 
Corpus callosum hypoplasia 2 
Dilated fourth ventricle 2 
Trigonocephaly 2 
Facial nerve aplasia 1 
Pinealoma 1 
Hamartoma 1 
Hydrocephalus 1 
Bulbar atrophy  1 
Cisternal dilatation 1 
Malignant neoplasm of encephalon  
(after surgery) 
1 
Pellucid septum cyst 1 
Dilated subarachnoid space 1 
Focal ischemic lesions 1 
Microcephaly 1 
Lipoma 1 
(Occipital) Myelomeningocele 1 
Leukodystrophy 1 
Pachygyria 1 
Temporal lobe hypoplasia 1 
TAB IX – Brain anomalies that were found among 143 implanted children. 
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For statistical purposes, the main group was divided into subgroups, as follows (table X): 
 
GROUPS INCLUSION CRITERIA 
NUMBER 
OF 
CASES 
MAIN STUDY 
GROUP 
Cochlear implant recipients who were less than 18 years of age at the 
time of surgery and who presented neuroradiological findings at pre-
operative neuroimaging investigations. 
143 
SUBGROUP A Patients with inner ear malformations (with or without brain anomalies) 23 
SUBGROUP B Patients with internal auditory canal stenosis 7 
SUBGROUP C Patients with only inner ear malformations (without brain anomalies) 13 
SUBGROUP D Patients with only brain anomalies (without inner ear malformations) 102 
SUBGROUP E 
Patients with inner ear malformations AND brain lesions or 
abnormalities (with brain anomalies) 
17 
SUBGROUP F Monolateral CI 123 
SUBGROUP G Bilateral CI 20 
SUBGROUP H < 3 years of age at the time of surgery 61 
SUBGROUP I > 3 years of age at the time of surgery 82 
SUBGROUP J Patients with genetic mutations 35 
SUBGROUP K Cytomegalovirus 26 
SUBGROUP L Meningitis (as the cause of the hearing loss) 13 
SUBGROUP M Patients who presented EVA 21 
SUBGROUP N CHARGE association 3 
SUBGROUP O Demyelination 25 
SUBGROUP P Gliosis 36 
SUBGROUP Q Leukomalacia 25 
SUBGROUP R Patient with only cochlear malformations 9 
Table X – Different subgroups were defined to implement the statistical analysis. 
 
 
Fig. 5. – Perceptual outcomes of the MAIN STUDY GROUP with a cochlear implant at the six-year follow-up. 
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After 3 months of using the cochlear implant, more than half of the patients in the main 
study group did not achieve the 3th category of perception at the Geers & Moog scale; in the 
same group, the 50% of the children did not reach the 4th category at the 6-month follow-up, 
nevertheless they achieved the 5th category 6 months after (1-year follow-up). Only 2 years 
after cochlear implant activation, the majority of the patients attain a 6th perceptual category 
at the Geers & Moog scale (fig. 5). 
Statistical results are reported in full as the following graphs (fig. 5-15). These graphs 
show the comparison between the control group and each of the subgroups; nonetheless, 
different subgroups were compared.  
Graphs are structured as follows: on the abscissa axis are reported the number of cases, 
and they are distributed over the time of the 3, 6, 12, 24 and 36 month follow-ups, using a 
colour code for identification (red for the 3-month control, green for the 6-month control, 
blue for the 12-month control, violet for the 24-month control and azure for the 36-month 
control).  
There was a statistically significant difference (p ≤ 0.01) between the control group and 
the subgroup B (patients with internal auditory canal stenosis) at the 6-months follow-up. 
Similar results were obtained comparing control group and subgroup Q (patients affected by 
leukomalacia).  
At the 1-year and long-term (2-3 years) follow-ups, statistically significant differences (p 
≤ 0.05) were also found comparing control group and subgroups A,B, D and E, respectively. 
Comparing subgroups C and P we found that the first one achieved the "identification of 
verbal sounds" 6 months after device activation and the “vowel recognition” in closed set 
tests 6 months later; while the subgroup P more slowly reached the same perceptual skills. 
Nevertheless, at the long-term follow-up (2 years later) the results achieved by the two 
groups are optimal and similar (Fig. 8). 
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Fig 6. – In the figure are reported all of the statistical graphs that were obtained from the comparison between the subgroups 
A, B, C, D, E, J, M, O, P, and Q and the control group. Colour code for identification (red for the 3-month control, green for 
the 6-month control, blue for the 12-month control, violet for the 24-month control and azure for the 36-month control). * 
P≤0.05; ** P≤0.01. 
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Fig. 7 – Statistical data of the subgroups A, B, C, D, E, J, K, L, M, O, P, Q, and R. 
 
 
Fig. 8 - Comparison of the perceptual outcomes at the 3-month follow up on congenital hearing loss without progression 
(C) and progressive hearing loss (P). 
 
Figure 9 shows the statistical results obtained from patients with or without genetic 
mutations. 
As reported in table XI, the most common mutation was the 35delG in the GJB2 gene. All 
patients with SLC26A4 mutations presented bilateral EVA. Note that they had mutations on 
both alleles. Among these mutations, to our knowledge, 2 have never before described 
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(Q235R e G557D) and 1 was recently reported in one of our scientific publications entitled 
"Novel mutations in the SLC26A4 gene” [55]. 
 
 
Fig. 9 – Perceptual outcomes at the 3-month follow up on the children who underwent genetic investigation; differences 
between children with genetic mutations (+= mut) and children without mutations (─ = no mut) are shown in the graphs. 
 
GENE MUTATION N°  
GJB2 35delG/35delG 15 
GJB2 35delG/R184P 4 
GJB2 35delG/167delT 1 
GJB2 35delG/R143V 1 
GJB2 V27I/E114G 1 
GJB2 VS1+1G>A/delE120 1 
SLC26A4 G209V/Q235R 1 
SLC26A4 L445W/G557D 1 
SLC26A4 R409H/IVS2+1delG 1 
SLC26A4 R409H/Q235R 1 
MT-RNR1 (MIT DNA) C722X (homoplasmy) 1 
Tab. XI – Mutations that were found among 143 implanted children. 
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Fig 10 - Perceptual outcomes of subgroup M (EVA) at the 3-year follow-up 
 
After 3 months of using the cochlear implant, more than half of the patients belonging to 
the subgroup M (patients who presented EVA) did not achieve the 3th category of perception 
at the Geers & Moog scale; in the same group, the 50% of the children did not reach the 4th 
category at the 6-month follow-up, nevertheless they achieved the 5th category 6 months 
after (1-year follow-up). Only 2 years after cochlear implant activation, the majority of these 
patients attained a 6th perceptual category at the Geers & Moog scale (fig. 10). There was a 
statistically significant difference (p ≤ 0.05) between the control group and the subgroup M 
(patients who presented EVA) at the 1-year follow-up (Fig. 6). 
 
 
Fig 11 - Comparison between the perceptual outcomes at the 3-year follow-up of children who were younger than 3 years 
old at the time of surgery and who belong to subgroups C and E. 
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Given the great importance of timing of surgery for the CI outcomes we compared the 
results obtained from patients with only malformations of the inner ear (subgroup C) and 
patients with inner ear and concomitant brain abnormalities (subgroup E); then we divided 
these patients in those who underwent CI within 3 years of age and those who underwent CI 
after 3 years of age (Fig. 11-12). Similarly, we compared the patients with only brain 
abnormalities (subgroup D) and patients with inner ear malformations and concomitant brain 
abnormalities (Fig. 13-14). 
 
Fig 12 - Comparison between perceptual outcomes at the 3-year follow-up of children who were older than 3 years of age at 
the time of surgery and who belong to the subgroups C and E. 
 
In our study, it should be noted that the performance after bilateral CI (Fig. 15) can be 
influenced down by the fact that results were collected starting from the first CI (dragging 
effect of the second device over the first one) and in case of a delay in the second CI 
(sequential surgery), the perceptual skills, at the 1-year follow-up, can still be related to the 
“effect” of the first CI and likely due to differences in time of using the second device. 
Comparing unilateral CI and bilateral CI (sequential in almost all cases), it was noted that, at 
the 1-year follow-up, 1 device allowed vowel recognition in closed set tests in 50% of 
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patients (4
th
 perceptual category), while 2 devices enabled 50% of patients to achieve speech 
recognition in open set tests (6^ perceptual category).  
 
 
Fig 13 – Comparison between perceptual outcomes at the 3-year follow-up of children who are younger than 3 years of age 
at the time of surgery and who belong to the subgroups D and E. 
 
 
Fig 14 - Comparison between perceptual outcomes at the 3-year follow-up of children who are older than 3 years of age at 
the time of surgery and who belong to the subgroups D and E. 
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Monolateral 
CI 
 1 year  
follow up 
3 year  
follow up 
5 year 
 follow up 
Main group  
(n° 123) 
2 4.5 6 4.5 6 6 6 6 6 
meningitis  
(n° 10) 
1 2 4 2.5 5 6 6 6 6 
Cytomegalovirus  
(n° 21) 
3 6 6 6 6 6 6 6 6 
Bilateral  
CI 
Main group 
 (n° 20) 
3 6 6 6 6 6 6 6 6 
meningitis  
(n° 3) 
6 6 6 6 6 6 6 6 6 
Cytomegalovirus  
(n° 5) 
3 5 6 6 6 6 6 6 6 
Fig. 15 – Comparison between perceptual outcomes at 1-, 3-, and 5-year follow-ups of children who have 1 or 
2 cochlear implants among the MAIN GROUP and subgroups K and L. 
 
More evident was the difference comparing 1 and 2 CI among patients belonging to the 
subgroup L in terms of rapidity in achieving the higher perceptual categories; in fact all 
bilateral cases had reached the "open set recognition" at the 1-year follow-up. In the 
subgroup L, there were 3 patients with post-verbal, simultaneous and bilateral CI (Fig. 15). 
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4. DISCUSSION 
 
In the present era, when cochlear implantation is a widely accepted therapy for 
sensorineural hearing loss, the selection of the patients is still a complex issue demanding 
close collaboration of experts in all different fields. There is no doubt that thorough 
radiological evaluation is of enormous importance in malformed inner ears. An exact 
description and, if possible, classification of the abnormality builds the firm base of further 
evaluation. The results obtained allow us to affirm that abnormalities of the ear and brain are 
frequent findings among the cochlear implant candidates; for this reason, the neuroimaging 
has a fundamental diagnostic role. HRCT scans of the temporal bone help to define the 
surgical anatomy and provide information about cochlear abnormalities that can aid the 
surgeon in surgical planning and patient counselling. Temporal bone CT scans should be 
obtained and reviewed for evaluation of cochlear malformation, cochlear ossification, 
enlarged vestibular aqueduct, and other inner ear and skull base anomalies. An absolute 
contraindication to cochlear implantation detectable by HRCT is the absence of the cochlea 
in Michel’s aplasia. Although HRCT is the gold standard for evaluating most aspects of 
temporal bone anatomy, MRI is ideal in imaging soft tissue structures such as the 
membranous labyrinth and nerves. MRI can identify the presence or absence of fluid within 
the cochlear turns and the size of the cochlear and vestibular nerves within the internal 
auditory canals. MRI is superior to HRCT in determining cochlear obstruction due to non-
ossified scarring. One disadvantage to using MRI in children, though, is the need for 
sedation [56]. 
Patients with severe inner ear malformations are expected to perform more poorly than 
patients with normal cochlea because of the likelihood of fewer spiral ganglion cells and the 
more complex surgery in malformed ears. Nevertheless, different types of electrode arrays 
have been introduced to improve the placement of device and to develop speech 
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performance. Because the electrodes may not be confined by scalar anatomy, electrode 
migration may occur, and individuals with cochlear malformations may require frequent 
reprogramming of the electrodes. Electrodes that are not intracochlear or that elicit facial 
nerve stimulation can be eliminated from the “map” as can electrodes that elicit facial nerve 
stimulation in implanted normal cochleae. 
In previously published papers, several authors have shown that the benefits of implants in 
malformed inner ears are comparable to those gained by deaf children with morphological 
normal ears [13,36,38,57,58]. Indeed assert that cochlear implantation can be successfully 
performed in children with inner ear malformations. The various types of inner ear 
malformations may have quite different prognoses for good auditory performance. In cases 
of cochlear ossification, the functional effects remain especially controversial. Predictors of 
good performance include the constellation of incomplete partition of cochlea: enlarged 
vestibular aqueduct (EVA), dilated vestibule (i.e. Mondini’s malformation), isolated EVA 
and partial semicircular canal aplasia. These patients achieve a different level of open set 
recognition in over the 80% of cases. Children with other cochlear dysmorphologies such as 
the common cavity or with associated pathologies like the CHARGE association and 
psychomotor retardation–developmental delay can have poor performance after 
implantation. Obtaining knowledge of cochlear malformation is especially important in 
counselling parents before implantation [36].  
Kim et al. [13] observed that cochlear nerve hypoplasia was responsible for poor CI 
outcome, that reduced the chance of an acceptable development of perceptual and linguistic 
capabilities. Other malformations can be responsible for delay in reaching the higher 
categories at the Geers & Moog scale. Nevertheless, they found no significant differences 
between the study group (with inner ear malformations) and control group (without inner ear 
malformations) at the 2-year follow-up. Loundon et al. [38] reported similar results, that are 
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summarized as follows: (1) at the 12-month follow-up, 83% of children achieved 75% of 
speech recognition in closed-set tests (corresponding to the 5th category at the Geers and 
Moog scale); (2) only 16% of those patients had obtained the same results during pre-
operative tests; (3) at the 2-year follow-up, they improved the perceptual abilities and (4) 
64% of children achieved 50% of speech recognition in open-set tests (corresponding to the 
6th category at the Geers and Moog scale).  
Eisenman and colleagues found that all the subjects of their study showed improved 
performance on all measures of speech perception over time. Overall, the two groups 
showed no statistically significant differences in performance at 6 and 24 months. However, 
subjects with malformed cochleae evidenced slower rates of improvement than did their 
matched control subjects. Subjects with more severe malformations demonstrated poorer 
performance, but this may have been attributable to preoperative factors rather than to 
implant performance [57]. 
Incesulu and colleagues say that except cochlear or cochleovestibular nerve agenesis, inner 
ear malformations cannot be accepted as a contraindication for cochlear implantation. 
Although there can be difficulties during the surgery or in the postoperative period, patients 
with inner ear malformations can also benefit from cochlear implantation. It is essential that 
all possible complications and postoperative performance should be discussed with the 
parents [58]. 
Although there is controversial data in the literature on the prognostic value of specific 
factors, such as cochlear malformations and brain abnormalities, we can conclude that these 
factors do not necessarily affect the outcome of the cochlear implant; in fact, most of the 
factors that are typically encountered achieve satisfactory results. With the exception of a 
few special cases, such as stenosis of the internal auditory canal (<2 mm) and the common 
cavity, or instead the lack of the modiolus, which prevents an optimal pairing between 
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electrodes and cochlear nerve fibres, the results, especially over a long-term period, are 
comparable to patients without neuroimaging findings, in terms of the achievement of 
perceptual abilities. 
However, we must stress that, especially in the short term period (12 months), the presence 
of cochlear malformations could slow the attainment of more complete perceptual abilities; 
even more evident is the effect in the presence of disorders of the central nervous system. 
Note that the simultaneous presence of the inner ear malformations and anomalies of the 
brain determines a negative synergistic effect, with the achievement of lower perceptual 
categories (according to the Geers & Moog score) for the same period of use of the cochlear 
implant.  
In the present study, 28% of implanted children were affected by brain anomalies 
identified by pre-operative neuroimaging. Our results compare well with similar studies. 
Trimble et al. found central MRI abnormalities in 40% of the patients in their group 
compared to 20% in the study performed by Lapointe et al. [30]. Lapointe emphasized the 
importance of neuronal migrational delays resulting in the neurodevelopmental delay and 
potentially poor outcome from cochlear implantation. In addition to the brain MRI findings 
mentioned helping to predict speech perception and language outcome Trimble et al. also 
commented on the importance of some findings to the anaesthetist (ventriculomegaly, 
hydrocephalus, Chiari malformation and intracerebral haemorrhage) [28]. Of the 
abnormalities detected, 49% were related to known pre-existing conditions. By far the most 
common abnormality detected in 84 patients was white matter changes (70%) and this was 
found in 13% of all patients investigated. Frequently the white matter changes were related 
to previous conditions/insults and included infection, ischaemia, hypoxia and prematurity. 
Apart from diagnosing incidental findings, MRI brain can aid in the diagnosis of hearing loss 
and has been shown to be important in predicting language and speech perception outcomes 
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in patients with kernicterus and Cytomegalic virus (CMV) infection as etiological factors 
[29,59]. White matter changes have been shown to be an important determination of 
abnormal neurodevelopmental outcome and might help predict future problems (seizures and 
intellectual impairment) in certain patients [60.]. The full role of white matter changes in 
predicting hearing outcome in cochlear implant patients is still unclear. 
A further potential advantage of pre-operative brain MRI is that it might identify pathology 
that can be followed up with CT imaging, which is easily accessible post cochlear 
implantation. This was the case in three of the patients in this series with a lipoma, a 
hamartoma and a pinealoma diagnosed on brain MRI whom required further imaging after 
cochlear implant. In addition brain MRI will also provide a baseline for comparison with 
future MRI scans. 
The group of patients with bilateral implantation was very heterogeneous by virtue of the 
great variability in the time of execution of the second cochlear implant; thus, it was not 
possible to determine the effect in the subgroups. We have focused the investigation on those 
patients with meningitis and cytomegalovirus infection because the number of cases 
available for comparison was higher and more homogeneous. Either subgroups (K and L) 
show a significant improvement after 1 year after the activation of the second cochlear 
implant. 
In children, the most likely cause of cochlear ossification is meningitis. Twenty per cent 
of children acquire profound bilateral sensorineural hearing loss prior to the age of 3 years; 
90 per cent of these cases are meningitic in origin.[61] Labyrinthitis ossificans results from 
severe inflammation of the inner ear and can be associated with a variety of pathology 
(advanced otosclerosis, viral or bacterial labyrinthitis, and autoimmune inner ear disease). 
Labyrinthitis ossification presents one of the greatest challenges to effective, safe cochlear 
implantation. Green and colleagues demonstrated that ossification due to meningogenic 
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labyrinthitis extended further into the cochlea than ossification due to other causes. The extra 
bone growth makes the insertion of the electrode a difficult process [62]. In addition, the 
stimulation of surviving neural elements may be compromised by the bony obliteration, and 
histopathololgic reports have shown an association between the degree of bony occlusion 
and a decreased number of surviving spiral ganglion cells, particularly in cases of bacterial 
meningitis[63]. For these reasons, patients with labyrinthitis ossificans were often thought to 
perform at lower levels than those without ossification. In previously published papers 
[64,65], several authors have shown that that children with postmeningitic hearing loss and 
cochlear ossification could attain significant benefit from their implant, although children 
without ossification were likely to perform better. A key factor for success may be the timing 
of implantation. Ossification may appear as early as 2 months following meningitis, leaving 
a small time period during which electrode insertion is optimal. As mentioned previously, 
however, central nervous system sequelae of meningitis are likely to hold sway in 
determining outcome [66].  
Hearing loss is the most common manifestation of congenital CMV infection making 
CMV a leading cause of nonhereditary congenital hearing loss [67.]Cytomegalovirus (CMV) 
is one of the most common congenital viral infections. The manifestations of CMV infection 
cover a broad spectrum ranging from asymptomatic to severe systemic disease resulting in 
significant morbidity and mortality. 90% of infants with congenital CMV are asymptomatic 
at birth. Despite being asymptomatic at birth, up to 7% of these children will develop 
sensorineural hearing loss that can be unilateral or bilateral, fluctuating or progressive, and 
range from mild to profound [68]. Approximately 10% of infants with congenital CMV are 
symptomatic at birth, and 40% of these patients will develop sensorineural hearing loss [69]. 
Given the relatively large number of children potentially affected by CMV-related hearing 
loss and the wide range of manifestations of congenital CMV infection, it is difficult to 
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predict how a child with symptomatic CMV will perform with a cochlear implant. 
Congenital CMV infection accounted for a significant proportion of patients with SNHL, 
with an incidence rate comparable with that of GJB2-related SNHL. 
Previous studies have shown that brain imaging may be a good predictor of adverse 
neurodevelopmental outcomes. In a study of children with a diagnosis of SNHL, 80% of the 
CMV positive children had abnormal brain MRI scans compared with only 33% of CMV 
negative children [70]. Our study demonstrated that certain imaging findings may correlate 
with worse outcomes after CI. Interestingly, the location of the abnormalities also seemed to 
correlate with worse perceptive outcomes. The majority of the abnormalities were found in 
the temporal lobe and parietal lobe. The parietal lobe processes sensory information and 
houses our language abilities, and the temporal lobe regulates emotion, hearing, language, 
and learning, which could explain why language outcomes are poorer in children with 
abnormalities in these regions.  
Children with symptomatic congenital CMV appear to derive benefit from CI albeit at a 
slower rate. In a study of 13 children with symptomatic congenital CMV, 73% of implanted 
children achieved closed-set word recognition, and 63% achieved open-set word 
recognition[29]. Ramirez Inscoe and Nikolopoulos demonstrated mixed results for speech 
perception and intelligibility with 50% of children with congenital CMV performing more 
poorly than controls, 31% performing similarly, and 19% performing better than controls 
These children did, however, derive auditory benefit from cochlear implant. [71].  
Although our study has limitations including its retrospective nature and small sample 
size, it provides data that may further efforts to identify factors which may help predict 
which children with congenital symptomatic CMV will benefit from CI, albeit at a slower 
rate than other children. The location of central nervous system abnormalities, including 
gliosis and calcifications, may play a role in audiometric and perceptive outcomes after CI. 
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Early measurements such as brain imaging findings and internal ear imaging findings may 
allow for more accurate counselling of families regarding anticipated post-implantation 
performance in children with symptomatic congenital CMV. 
Cochlear implants can have impressive effects on a child’s language abilities, yet 
outcomes remain variable across the paediatric population. Numerous studies have thus 
attempted to identify predictors determining post-implantation communication. So far, 
relevant factors are age at onset of deafness, age at implantation, length of implant use, 
amount of residual hearing, duration of deafness, educational mode and resources, and 
psychosocial elements. 
A clear factor seems to be the age at implantation: children appear to perform better when 
implanted at earlier stages.[72] On IT-MAIS testing, Robbins and colleagues found that 
children implanted under the age of 19 months demonstrated faster progress and higher 
scores than those implanted between the ages of 2 and 3. As Geers found, though, this age 
advantage disappears after 2 years, implying a critical period of development within the first 
2 years of life. At older ages, then, other factors begin to affect implant performance [50]. 
Although it is known from the literature that the precocity of diagnosis and treatment is an 
important prognostic factor in the auditory / habilitation, in our study the difference between 
the patients that, at the time of surgery, were younger than 3 years of age and those who 
were older than 3 years was not significant or at least fell short of expectations. More 
specifically, children who received implants within 3 years of age showed the worst results 
in the early controls (3 months); we cannot exclude a bias of the study due to the fact that 
children implanted at an early age, at three months after the implant activation, are not able 
to express perceptual skills that were included in the classification that was used. 
Nevertheless, at the 6 month follow-up, they started to show the "overtaking" effect in their 
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perceptual performances. The outcome is not significantly different between the two groups, 
starting from the 1-year follow-up. 
Paediatric audiological services should offer children with sensorineural hearing loss 
testing for mutations in Connexin proteins because mutations in at least two Connexins have 
been implicated in nonsyndromic hearing (GBJ2 and GBJ6). As mentioned above, the most 
frequent mutation is found in Connexin 26 encoded by the GBJ2 gene (35delG), resulting in 
DFNB1 [73]. Mutations in Connexin 26 result in sporadic and familial severe/profound 
prelingual hearing loss [20] and account for about 50% of recessive and 10% to 25% of 
sporadic nonsyndromic hearing loss in Southern European children. An evaluation from 
United States has shown that nearly 30% have Connexin 26–related hearing loss with all 
degrees of hearing loss [73] and thus it can be stated that mutations in Connexin 26 may 
result in all degrees of hearing loss. Thus, it is recommended that all children under 18 years 
of age with bilateral, permanent, nonsyndromic sensorineural or mixed hearing loss, 
irrespective of the level of impairment, for which there is no other explanation, should be 
offered testing. The initial testing should check for 35delG and/or the other most frequent 
mutations in the background population. Unless the first screening identifies mutations on 
both alleles, testing should go on to screening of the entire coding region and splice sites for 
mutations. In addition, the presence of GBJ6/Cx30 deletions should be sought. 
The perception at 3, 6, 12, 24, and 36 months shows no significant differences between 
subjects with genetic mutations (35delG in almost all cases) and patients without mutations. 
However, the obtained results show how the concomitant presence of malformations of the 
inner ear in the group of patients with mutation moves away from the expected outcome in 
patients with the same mutation but without abnormalities of the inner ear. The percentage of 
patients with mutations in our study group does not differ from the rates observed among 
patients without neuroimaging findings. This finding means that we are still far from 
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establishing the true contribution of DNA mutations on the anatomy and development of the 
ear and brain. Therefore, it can be concluded that the detection of an abnormality of the ear 
or brain should not prevent the execution of genetic testing for mutations that are known to 
be those that are not associated with malformations (e.g., mutations in the gene GJB2). 
As part of the protocol for diagnostic evaluation imaging techniques should be used in order 
to detect aplasia/hypoplasia and/or malformations such as enlarged vestibular aqueduct 
(EVA). EVA is often found in subjects with Pendred syndrome that is a recessive genetic 
hearing disorder. The gene responsible for Pendred syndrome has been located to 
chromosome 7q31 and designated PDS (SLC26A4). The gene product, pendrin, is a 
transmembrane chloride-iodide cotransporter protein, probably essential for endolymphatic 
homeostasis. Sensorineural hearing loss may be fluctuant or progressive, ranging from mild 
to profound. The diagnosis of Pendred syndrome (or DFNB4) in such cases depends on 
analysis of mutations in the PDS gene, where the most frequent mutation is the SLC26A4 
[55]. An enlarged vestibular aqueduct remains the most common malformation of the inner 
ear, but it does not appear to influence the outcome of the cochlear implantation. 
There were no significant differences between the group of children who had congenital 
profound hearing loss and children with progressive hearing loss, in either the short- or the 
long-term period. Comparing the perceptive outcomes of subgroups C (with inner ear 
malformations) and E (inner ear malformations with brain abnormalities) shows a significant 
difference starting from the 6-month follow-up (P <0.05), which becomes more and more 
evident over time (at a 2- and 3-year follow-up, P <0.01), in favour of those subjects who 
have only malformations of the inner ear and who have better performances. 
We also compared the outcomes of the subgroups D (brain anomalies) and E (inner ear 
malformations with brain abnormalities) and, in this case, the differences begin to emerge at 
12 months from the cochlear implantation (P <0.05); they become more significant over time 
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(at a 2- and 3-year follow-up, P <0.01), in favour of those that have only brain anomalies 
that have better performances. 
Brain anomalies affect the long-term outcome after cochlear implantation the most, 
especially among children who were older than 3 years of age at the time of surgery; 
comparing those children who belong to subgroups C and E showed an increasingly 
significant difference starting from 6 months (P <0.05) after the cochlear implant activation. 
Furthermore, children who were older than 3 years of age and who belonged to subgroups D 
and E did not show any significant difference, from the underlying “dominant effect” of the 
brain abnormalities. This “dominant” effect appears to be less evident among the children 
who are younger than 3 years of age at the time of surgery, probably due to the greater 
neuronal plasticity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
  
59 
5. CONCLUSIONS 
 
A cochlear implant is a relatively safe and effective treatment for patients who have inner 
ear malformations and abnormalities of the brain. The aetiology remains unknown in most 
cases (18.9%). The cytomegalovirus infections are the main form of acquired deficit. The 
genetic mutation that is the most common among patients in this study remains the 35delG 
GJB2 gene. The EVA is still the most common malformation of the inner ear, but it appears 
to have no specific effect on the outcome of the cochlear implant. 
Gliotic injuries and disorders of the white matter brain abnormalities were more frequent, 
which in general showed a dominant effect on the outcome that was negative. Especially 
difficult is fitting the result and the outcome of patients with stenosis of the internal auditory 
canal or in the presence of malformations with the cochlear absence of the modiolus. 
Neuroimaging has been vital for a correct diagnosis and proper pre-operative evaluation of 
cochlear implant candidates. Furthermore, the obtained data could be useful in defining the 
most appropriate timing of the follow-up, in specific cases and, if necessary, to develop 
better rehabilitation strategies in the event that the outcomes differ from the expected 
outcomes. 
The CI outcome depends on many variables that range from the age at the time of the 
surgery to the communication mode. Nonetheless, before demanding a multidisciplinary 
approach, the otologist (or audiologist) has the responsibility to verify the correct 
functioning of the device, requiring, if necessary, a manufacturer's report to rule out 
technical failure. Afterwards, a clinical team should manage such unsatisfactory 
performances, after CI, starting from a self-review process of the applied paths (in terms of 
auditory rehabilitation or speech training), in order to detect errors in their settings. If there 
are persisting doubts concerning with the CI results after a technical and methodological 
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review for challenging cases, the first functional and aetiological diagnosis should be 
reconsidered and re-evaluated by a multidisciplinary team. 
Cooperation between parents, school administrators, teachers, and speech specialists is also 
vital to the success of the child. 
Although further studies are necessary for the identification of predictive factors, especially 
in challenging cases, the results of the present study have confirmed the need to carry out 
diagnostic, therapeutic and rehabilitation processes in specialised centres with extensive and 
proven experience.   
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NEUROIMAGING ATLAS 
 
 
Lane J, Witte RJ. The Temporal Bone: An Imaging Atlas. Springer 2010 
Fig. 16 – The inner ear. Right anterior oblique views of 3D reconstructions from microscopy data sets. (b) 
Micro CT reconstruction of the bony labyrinth. (c) Micro MR reconstruction of the membranous labyrinth to 
include the perilymphatic and endolymphatic spaces. (d) Micro MR reconstruction of the endolymphatic 
structures of the membranous labyrinth only. Note the anterior position of the scala vestibuli and the posterior 
position of the scala tympani within the cochlea [74] 
 
 
Lane J, Witte RJ. The Temporal Bone: An Imaging Atlas. Springer 2010 
Fig. 17 – Innervation of the inner ear. (a) Lateral and (b) medial views of the membranous labyrinth. Superior 
and inferior vestibular nerves innervate the vestibular apparatus and the cochlear nerve innervates the auditory 
apparatus of the cochlea. 
The cochlear nerve is composed of efferent fibers from all the spiral ganglia cells found at the base of the spiral 
lamina. They arborize through multiple small channels within the modiolus and coalesce within the cochlear 
nerve aperture at the apex of the internal auditory canal (IAC). Spiral ganglia cell afferent fibers transmit input 
from the hair cells of the organ of Corti within the cochlear duct (scala media) 
Note that the superior vestibular nerve has an ampullary branch supplying the cristae ampullaris of the superior 
and lateral semicircular ducts and a utricular branch supplying the utricular macula. The inferior vestibular 
nerve has two branches, the saccular branch innervating the saccular macula, and the posterior branch, 
innervating the crista ampullaris of the posterior semicircular duct. [74]. 
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Fig. 18 - Normal ear, CT scan, axial image: 1 = internal auditory canals; 2 = lateral semicircular canals; white 
arrows = vestibular aqueducts; black arrow = cochlea (modiolus); white X = facial nerves. 
 
 
Fig. 19 - CT and MRI temporal bone; black asterisks = enlarged vestibular aqueduct (EVA).  
63 
 
 
Fig. 20 - CT and MRI temporal bone scans with 3-D MR imagines showing bilateral hypoplastic cochlea with 
normal basal turn. 
 
 
Fig. 21 - Incomplete Partition Types [45] 
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Fig. 22 - CT and MRI temporal bone, 3-D MR imagines. The bony labyrinth presents as one large cystic 
structure without differentiation of the cochlea or the semicircular canals, there are only small bud like recesses 
anteriorly and posteriorly shown, common cavity. 
 
 
Fig. 23 - CT and MRI temporal bone. Hypoplastic cochleae and dilated saccules. 
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Fig. - 24 CT and MRI temporal bone, 3-D MR imagines; bulbous dilatation of the fundi of the internal auditory 
canals and congenital stenosis of superior semicircular canals.  
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Fig. 25 - Temporal bone CT scan - Axial and coronal images: a), c), d), normal ear; b) hypoplastic/cystic 
cochlea, modiolus absent, anomalous facial nerve course, absence of the vestibular system; c) malformed and 
dislocated ossicular chain, cochlear malformation (hypoplasia); f) g) absent semicircular canals. 
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Fig. 26 - Axial CT scan showing an incomplete partition type III (black arrows) and cystic aspect of the 
vestibular system (red arrow). 
*
 
 
Fig. 27 - MRI and CT scans of temporal bone (right ear) revealing a cystic cochlea (white asterisk) and dilated 
vestibule (black asterisk). 
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Fig. 28 - CT scan, axial image of temporal bone: incomplete partition type I. 
 
 
 
 
Fig. 29 - CT and MRI revealing an incomplete partition type II in a patient affected by CHARGE association. 
 
 
*
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Sensi A, Ceruti S, Trevisi P, Gualandi F, Busi M, Donati I, Neri M, Ferlini A, Martini A. LAMM syndrome with middle ear 
dysplasia associated with compound heterozygosity for FGF3 mutations. Am J Med Genet A. 2011;155A(5):1096-101. 
 
Fig. 30 - LAMM syndrome (A) CT scan. Second bend and vertical tract of the right facial nerve. (B) CT scan. 
On the both sides are evident hypoplasia of incus and aplasia of staple. (C) CT scan. First and second 
intracanalicular tract of facial nerve.(D) CT scan. Left facial nerve’s canal. (E) MRI. Evident facial nerves 
(arrows), not evident acoustic nerves on the both sides. The left internal auditory canal is hypoplastic, while the 
right is aplastic. Bilateral absence of the membranous labyrinth’s signal. (F) CT scan. Remarkable hypoplasia 
of the left internal auditory. (G) MRI. Sagittal oblique scan: evident the intracisternal tract of the left facial 
nerve (arrow) [49]. 
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Fig. 31 - LAMM syndrome (A) MRI scan. The image show facial nerves at the cisternal site (arrows); is not 
possible to see the normal signal hyperintensity of internal auditory canal and membranous labyrinth on the 
both sides. (B) CT scan. Bilaterally malleus’ dysplasia (thick handle and irregular head). The facial canal is 
evident cranially to the middle ear (arrows); note the otic capsule substituted by a thin bony sheet and a 
remarkable hypoplasia and orizontalization of the ear drums. (C) CT scan. Bilateral aplasia of otic capsules. On 
the both sides is present staple (arrow) and absent oval window [49]. 
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Fig. 32 - CT and MRI scans. After-effects 
of CMV meningo-encephalitis, with 
patchy lesions of the white matter (red 
arrow) and dilation of the left lateral 
ventricle. 3-D MR image of a case of 
semicircular canal occlusion, complication 
of CMV meningo-encephalitis 
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Fig. 33 A. – Cystic cochleae with apical turn aplasia, dilated vestibules, hypoplastic semicircular canals.  
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Fig. 33 B – MRI; dilated cisterna magna (or cerebellomedullary cistern); hypoplasia of the corpus callosum; 
dilated fourth ventricle; gray matter heterotopia; post-surgical anatomy of occipital myelomeningocele closure. 
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Fig. 34 MRI scans. hypoplasia of the corpus callosum; dilated lateral ventricles (external hydrocephalus 
 
 
 
 
Fig. 35 MRI scans. CMV meningo-encephalitis, with patchy lesions of the white matter and dilation of the 
lateral ventricle; red arrow: pineal cyst. 
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Fig. 36 – MRI scans. Cortical dysplasia. 
 
 
 
Fig. 37 - MRI scans. Parieto-occipital dysmyelinating areas, characterized by abnormal hyperintense signal on 
T2-FLAIR image in frontal and parieto-occipital periventricular regions 
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Fig. 38 MRI scans. This is an example of periventricular leukomalacia; you can see reduction of the 
periventricular white matter, abnormal hyperintense signal (on T2-FLAIR image) (of the white matter) in 
parieto-occipital periventricular regions and “ex vacuo” dilation of the frontal horns. Red arrow: pineal cyst. 
 
 
 
Fig. 39 - CT and MRI scans. Hypoplastic lateral semicircular canal; lypoma of the corpus callosum; agenesis of 
the posterior part and splenium of the corpus callosum; pellucid septum cyst; dilated cisterna magna (or 
cerebellomedullary cistern). 
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